Skip to main content
Day.News — Local News. Real Community.
247 neighbors reading now

Grove City Day News

Small-town charm, big-city access, hometown pride.Grove City, OH Edition
health
5 min read

CDC Study Links Opioid Painkiller Use in Early Pregnancy to Increased Risk of Birth Defects

June 11, 2026

A study by the Centers for Disease Control and Prevention (CDC) suggests that women who used opioid painkillers shortly before or during early pregnancy faced a slightly elevated risk of having babies with birth defects. The research examined the potential effects of drugs such as codeine, oxycodone, and hydrocodone.

The CDC researchers analyzed data to identify potential links between specific opioid medications and the occurrence of birth defects. Researchers emphasized the increased risk was modest. The study accounted for other factors that could influence birth defect rates.

The findings do not prove that opioid painkillers directly cause birth defects. Further research is needed to fully understand the nature and magnitude of the association. The CDC recommends women who are pregnant or planning to become pregnant discuss pain management options with their healthcare providers.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

0 ratings submitted

How do you feel about this story?

NA

National Desk

Trust 3.315214 articles1,145,197 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

U

Be respectful and thoughtful in your comments.

Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Upcoming Events

Advertisement
Sponsor Message

Related Stories

U.S. Announces Visa Restrictions on Associates of Alleged Fentanyl Traffickers

U.S. Announces Visa Restrictions on Associates of Alleged Fentanyl Traffickers

Hantavirus Suspected in Cruise Ship Deaths, Illnesses

Hantavirus Suspected in Cruise Ship Deaths, Illnesses

DNA Test Could Spare Millions of Breast Cancer Patients From Chemotherapy

DNA Test Could Spare Millions of Breast Cancer Patients From Chemotherapy